Search - tctmd.com

Displaying 381 - 400 of 1432

Sort: Relevancy | Date

News Industry News

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

July 23, 2015

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Daily News

高灵敏度CRP可预测接受DES的患者的长期死亡率

L.A. McKeown

July 20, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

L.A. McKeown

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Daily News

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

L.A. McKeown

July 15, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Industry News

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

Advertisement

Eagle Pharmaceuticals’ RTU Bivalirudin NDA Accepted for Filing

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

高灵敏度CRP可预测接受DES的患者的长期死亡率

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

UK launch for Daiichi's bloodthinner Lixiana

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content